Abstract: A phased-array antenna that includes a photonic beamformer is disclosed. In some embodiments, a front stage of electrical-domain processing applies a 16-to-1 signal-combination ratio, a single stage of photonic beamforming applies a 4-to-1 signal-combination ratio, and a passive, electrical-domain, signal combiner applies a 32-to-1 signal-combination ratio.

Abstract: Gaseous molecules, such as H2, CO2 and CH4, can be separated using a hybrid organic-inorganic polyimide network membrane, wherein the polyimide contains bis-imide units of formula 1 (formula 1), wherein A represents an organic moiety having 2-22 carbon atoms; or corresponding tris-imide groups, wherein a nitrogen atom of two or more of said bis-imide units is linked to a group Q of a polyhedral oligomeric silsesquioxane (POSS) group of formula 3 QmR(2n-m)Si2nO3n.xH2O 3 wherein Q is CpHq bound to a silicon atom, R is hydrogen, hydroxy or C1-C4 alkyl, alkoxy, hydroxyalkyl, aminoalkyl or ammonioalkyl, bound to a silicon atom, m is from 2 up to 2n, n is from 2 up to 6, p=1 to 6; q=2(p?r) with r=0, 1, 2<p; and x is from 0 to 2n?1.

Abstract: The invention relates to a method and a device, suitable for the measurement of quantitative photon absorption coefficient in tissue, wherein the device comprises a first light source, suitable for generating photons, a light measurement element suitable for measuring at least one of: the intensity, the frequency, the frequency deviations and phase shift of the light to be measured, an ultrasound source, suitable for the generation of a defined sound wave pattern in a defined volume element within the tissue, wherein the ultrasound source is suitable for labelling the light, originating from the first light source or a second light source that enters the defined volume element within the tissue, and an ultrasound measurement element, suitable for measuring ultrasound, originating from the defined volume element within the tissue and generated by the light of the first light source that enters the defined volume element within the tissue.

Abstract: The present invention relates to a process for manufacturing a hollow fibre membrane having a supporting layer and a separating layer, said process comprising: (a) extruding a spinning composition comprising a first polymer and a solvent for the first polymer through an inner annular orifice of a hollow-fibre die; (b) co-extruding a composition comprising an organic nucleophilic reagent and a mixtures of a solvent and a non-solvent for the first polymer, wherein the composition is either extruded through a central annular orifice of the hollow-fibre die or through an outer annular orifice of a hollow-fibre die; and (c) passing the hollow-fibre through a coagulation bath. The hollow fibre membrane according to the present invention can be used in gas separation processes, vapour separation processes and liquid filtration processes.

Abstract: The invention relates to a method for making a 3D nanostructure having a nanosubstructure, comprising the steps of: i) providing a mold comprising at least one sharp concave corner; ii) conformational depositing at least one structural material in the sharp concave corner; iii) isotropically removing structural material; iv) depositing at least one other structural material; v) removing earlier deposited structural material; vi) forming a nanosubstructure; and vii) removing the mold thereby providing the 3D nanostructure having the nanosubstructure.

Abstract: The invention relates to a capsule or chip or sensor comprising a marker/detector and signalling device/method associated with the development of a medical condition/disease and to its use. This In Situ Lab On a Chip Signalling device (ISLOGS device) is used for detecting a medical condition/disease in situ or in vivo (inside the body), for example by swallowing it for testing in the digestive tract or by putting it into the vagina, mouth or nose. All reactions takes place in the body and when the test result is positive the device will notify the subject by colorizing the tested body fluid or biomaterial (for example faeces, urine or saliva) or the device itself. The detection is made outside of the body when the biomaterial or ISLOCS device has left the body.

Abstract: The invention relates to a system 10 for enabling generation of photoacoustic images, comprising a light source 3 arranged to generate pulsed or modulated light having a wavelength in the range of 200-2500 nm, a biopsy needle having a needle body 4 with a distal portion 4a, the needle body being provided with an optical fiber 5 having a distal portion 5a and adapted to conduct the light from the light source 3 via the distal portion 5a towards a target region 2 located inside a patient 1. Photoacoustic signals 7 generated in the target region 2 are advantageously intercepted by a suitable detector, such as a per se known ultrasonic probe 6. The ultrasonic probe 6 may be connected to a data processing system 8 for visualizing suitable images 9a on a display 9. The invention further relates to a method of generating photoacoustic images and to a biopsy needle.

Abstract: The invention relates to a method of manufacturing of a microneedle array comprising the steps of selecting a soft production mold comprising a set of microscopic incisions defining geometry of the microneedles, said soft production mold being capable of providing the microneedle array integrated into a base plate; using a filler material for abundantly filling the microscopic incisions of the soft production mold thereby producing the microneedle array with pre-defined geometry integrated into the base plate; wherein for the filler material a water or alcohol based ceramic or polymer-ceramic slurry is selected. The invention further relates to a microneedle array 16, a composition comprising a microneedle array, a system for enabling transport of a substance through a barrier and a system for measuring an electric signal using an electrode.

Abstract: The invention relates to a method of manufacturing of a microneedle array comprising the steps of selecting a soft production mold comprising a set of microscopic incisions defining geometry of the microneedles, said soft production mold being capable of providing the microneedle array integrated into a base plate; using a filler material for abundantly filling the microscopic incisions of the soft production mold thereby producing the microneedle array with pre-defined geometry integrated into the base plate; wherein for the filler material a water or alcohol based ceramic or polymer-ceramic slurry is selected. The invention further relates to a microneedle array, a composition comprising a microneedle array, a system for enabling transport of a substance through a barrier and a system for measuring an electric signal using an electrode.

Abstract: The invention relates to a scanning probe microscope comprising: a specimen holder holding a specimen; and a probe for scanning the relief of the upper surface of the specimen, which probe is movable in a vertical direction and two orthogonal horizontal directions, wherein the upper surface of the specimen is tilted relative to at least one of the two orthogonal horizontal directions.

Abstract: The invention is directed to a treatment of diabetes, a scaffold and a method of preparing a scaffold. In a first aspect, this object is met by providing a scaffold comprising beta cell aggregates, wherein the aggregates are distributed over the scaffold in a predetermined pattern.

Abstract: The present invention provides an optical device, comprising an optical fiber and a cantilever that is arranged on an end of the optical fiber; The cantilever may be an integral part of the optical fiber, and may have a length that is substantially equal to a diameter of the optical fiber. Measurement means for measuring a displacement of the cantilever are connected to an opposite end of the, optical fiber. A method of measuring a displacement using the optical device comprises the steps of: —arranging measurement means, comprising a light source, on an opposite end of the optical fiber; —using the light source to send a beam of light into the optical fiber; —measuring the interference of light that is reflected on the end op the optical fiber and light that is reflected on the cantilever; and determining the displacement of the cantilever relative to an intermediate position dependent on the measured interference.

Abstract: A thermoacoustic imaging apparatus comprises an electromagnetic radiation source configured to irradiate a sample area and an acoustic signal detection probe arrangement for detecting acoustic signals. A radiation responsive acoustic signal generator is added outside the sample area. The detection probe arrangement detects both signals generated in a sample area in response to the irradiation and an acoustic signal from the radiation responsive acoustic signal generator that has traveled through the sample area. A computing system distinguishes first acoustic signal detections attributed to the acoustic signal generated by the radiation responsive acoustic signal generator and second acoustic signal detections attributed to the acoustic signals generated by the sample area. The computing system performs a tomographic computation of an acoustic transmission parameter as a function of a position in the sample area from the first acoustic signal detections.

Abstract: The present invention relates to methods for providing shaped biodegradable and elastomeric structures of (co)polymers of 1,3trimethylene carbonate (TMC) with improved (mechanical) properties which can be used for tissue or tissue component support, generation or regeneration. Such shaped biodegradable elastomeric structures are obtainable by forming homopolymers and/or copolymers of 1,3-trimethylene carbonate (TMC) into a desired shape and irradiating said desired shape with actinic radiation in an inert atmosphere.

Abstract: Polarization-diverse optical devices and related methods are disclosed. In some embodiments, these devices and methods are realized by utilizing a four-port, wavelength-dependent optical coupler that is arranged to receive identical counter-propagating optical signals.

Abstract: The present invention provides an optical device, comprising an optical fiber and a cantilever that is arranged on an end of the optical fiber; The cantilever may be an integral part of the optical fiber, and may have a length that is substantially equal to a diameter of the optical fiber. Measurement means for measuring a displacement of the cantilever are connected to an opposite end of the, optical fiber. A method of measuring a displacement using the optical device comprises the steps of: —arranging measurement means, comprising a light source, on an opposite end of the optical fiber; —using the light source to send a beam of light into the optical fiber; —measuring the interference of light that is reflected on the end op the optical fiber and light that is reflected on the cantilever; and determining the displacement of the cantilever relative to an intermediate position dependent on the measured interference.

Abstract: In an integrated optical lightguide device including a light-transmitting core layer, an inclusion or buffer layer, and an active or cladding layer. The cladding layer is divided into segments. Groups of different segments exhibit different refractive indices, light intensity profiles or different degrees of sensitivity which have been effected by different methods. Thus, repeated adjustable or controllable transmission has resulted in an extremely sensitive waveguide system for a sensor, a modulator, or a spectrophotometer.

Abstract: The present invention relates to isolated and recombinant antimicrobial peptides thrombocidin-1 (TC-1) and thrombocidin-2 (TC-2), or variants thereof, which comprise at least in part the sequence as shown in FIG. 1 indicated by the label TC-1 and TC-2, and have antimicrobial activity against gram-positive and gram-negative bacteria, for example Escherichia coli, Bacillus subtilis, Streptococcus sanguis, Streptococcus pneumoniae, Staphylococcus epidermis, and Staphylococcus aureus, and/or against fungi, for example Candida albicans, C. glabarata, Cryptococcus neoformans, Aspergillus flavus, A. fumigatus, and Pseudoallescheria spec. The invention further relates to the use of said peptides, or variants thereof, for the preparation of a medicament for the treatment of bacterial or fungal infections, such as endocarditis, in humans and animals and the use of said peptides, or variants thereof, in release systems for prevention of bacterial or fungal infections in humans and animals.

Abstract: A device for separating liquid and/or gas components from each other, which device includes a ceramic membrane comprising a porous layer of &ggr;-alumina which is present on top of a porous layer of supporting material, wherein an alkali-free, phosphorous material is provided between said supporting material and said layer of &ggr;-alumina, and wherein said material preferably consists of monoaluminium phosphate.

Abstract: The present invention relates to a device for controlling a liquid flow in a liquid channel, comprising: an elongate liquid holder in which a liquid channel is provided in longitudinal direction; first voltage means for applying a first voltage difference over substantially the longitudinal direction of the liquid channel; a conductor member arranged in at least a part of the liquid channel against the liquid holder; an insulator member arranged in the liquid channel against at least the conductor member; second voltage means for providing a second voltage difference between the conductor member and the liquid in the liquid channel; wherein the thickness of the insulator member is a maximum of 1 &mgr;m and preferably in the order of magnitude of some tens of nanometres.